This article is more than 5 years old. Information may no longer be current.

Nicox reports year-to-date net loss

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Nicox reported a net loss of €13.6 million for the 9-month period ending Sept. 30, according to a press release.

For the same period a year ago, Nicox recorded a net loss of €4.6 million. The company cited an increase in operating expenses associated with the costs of building its commercial organization in the U.S. and Europe and a decrease in revenue as reasons for the loss.

Revenues were €0.3 million in the 9-month period, compared with €7.6 million for the corresponding period in 2012, which included a milestone payment from Bausch + Lomb.

Selling, administrative, and research and development costs were €13.6 million, up from €11.6 million a year ago. Forty-three percent of costs related to selling expenses due to the transformation of Nicox into a commercial ophthalmic company.